Phreesia (PHR) Gross Margin (2018 - 2026)

Phreesia (PHR) posted Gross Margin of 86.51% for Q2 2026, up 1.72% sequentially from 85.05% in Q1 2026, and up 86.0% YoY from 46.51% in Q2 2025.

Phreesia (PHR) Gross Margin (2018 - 2026) Analysis & Trends

Phreesia has reported Gross Margin for 9 years, with the latest figure at 86.51% in Q2 2026.

Quarterly Gross Margin rose 86.0% year-over-year to 86.51% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 85.39% (up 85.0% YoY) and the FY2026 annual result came in at 85.15%, up 93.0% from the prior year.
Gross Margin advanced to 86.51% in Q2 2026 per PHR's latest filing, from 85.05% in the prior quarter.
Over five years, Gross Margin peaked at 86.51% in Q2 2026 and troughed at 77.29% in Q2 2022.
A 5-year average of 82.76% and a median of 83.22% in 2023 frame the typical range for Gross Margin.
The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 504 bps in 2022, then surged 508 bps in 2023.
Over 5 years, Gross Margin stood at 80.08% in 2022, then increased by 4 bps to 83.05% in 2023, then grew by 0 bps to 83.28% in 2024, then advanced by 2 bps to 84.76% in 2025, then increased by 2 bps to 86.51% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 86.51%, 85.05%, and 84.76% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	74.98%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	12.72%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	72.27%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	74.48%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	86.44%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	57.35%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	69.44%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	84.87%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	83.00%
10	Phreesia	758.43 Mn	682.03 Mn	113.28 Mn	86.51%

Download Data